NYSE · GRMN

Garmin Ltd.

$243.03 +$2.93 (+1.22%) 1D After hours
Charting by TradingView

Key Metrics

$46.30B
Market cap
26.67×
P/E · TTM
$7.46B
Revenue · TTM
$1.74B
Net income
EPS · TTM $8.96
Dividend yield 1.5%
Free cash flow $1.45B
Beta · 1Y 1.17
EBITDA · TTM $2.25B
Gross margin 59.1%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    Money has been moving out of its sector (Technology).

    Technology has run -4.1 points vs SPY over four weeks, ranking 8→2→11→7 of 11 sectors — this stock trades inside that current.

    RECEIPT: ROTATION MAP, LIVE ↗
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Feb 18
    The stock moved +9.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 18

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$46.30B
Enterprise value—
Shares outstanding192.9M
52-wk range$186.67 – $273.32
Avg volume · 20D871.0K
Net cash —
Book value / share$47.86
IndustrySearch, Detection, Navigation, Guidance, Aeronautical Sys
ExchangeNYSE
About Garmin Ltd.
IPO dateDec 8, 2000
Employees23000

Garmin produces GPS-enabled hardware and software for five sectors: fitness, outdoors, automotive, aviation, and marine. Garmin has built a strong reputation for durable, high-precision devices through a vertically integrated design and manufacturing approach.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E26.67
P/S6.20
P/FCF31.90
EV/EBITDA—
EV/Sales—
Graham №$98.24

Profitability

Gross 59.1%
Operating 28.1%
Net 23.3%
FCF 19.4%
ROE / ROIC 20.3% · 26.4%

Financial Health

Current ratio4.36
Quick ratio3.02
Debt / equity—
Debt / EBITDA —
Net cash —
Working capital$4.62B

Cash Flow · TTM

Operating CF $1.75B
Capex −$297.00M
Free cash flow $1.45B
Buybacks —
Dividends paid $692.96M
Shareholder yield 1.5%

Piotroski F-Score

6 / 9
Middling fundamentals · 6 of 9 signals passing

Altman Z-Score

—
Insufficient balance-sheet inputs

Graham Number vs Price

$98.24 vs $243.03
Trades 2.5× above classic defensive value — priced for growth
Fundamentals through 2026-03-28 · computed by TickerWolf from SEC filings